StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
April 29, 2026 7:22 AM
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $3.00 price target on Opko Health (NASDAQ: OPK).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments